Nuwellis Inc (NAS:NUWE)
$ 0.2101 -0.008 (-3.67%) Market Cap: 3.79 Mil Enterprise Value: 3.10 Mil PE Ratio: 0 PB Ratio: 1.62 GF Score: 33/100

Nuwellis Inc at Oppenheimer Healthcare Conference (Virtual) Transcript

Mar 14, 2023 / 01:20PM GMT
Release Date Price: $4.72 (-1.36%)
Steve Lichtman
Oppenheimer & Co. Inc. - Analyst

Hi, everyone. I'm Steve Lichtman, medical devices analyst at Oppenheimer. Welcome back to the second day of the 33rd Annual Oppenheimer Healthcare Conference. Up next for us, we're very happy to have Nuwellis. With us today are Nestor Caramillo (sic - Jaramillo), CEO; and Lynn Blake, CFO.

We'll have a presentation here and then have some time for Q&A at the end. So if you do have a question, please key it in to the chat box. And I will make sure to get it right over to management.

But with that, I'm happy to turn the microphone over to Nestor. Thank you.

Nestor Jaramillo
Nuwellis, Inc. - President & CEO

Good morning, everyone, and thank you for joining the Nuwellis presentation. My name is Nestor Jaramillo, as Steve mentioned. And with me is Lynn Blake, our CFO. I like to start with the mission of Nuwellis, because I have -- I'm very fortunate to be working with a team that is really passionate about this mission that we have of transforming lives of patients suffering from fluid

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot